CG
DXCM icon

Cutler Group’s DexCom DXCM Stock Holding History

Cutler Group’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-455
Closed -$57.2K – 2578
2023
Q4 		$56K Buy
+455
New +$46.5K 0.01% 1379
2023
Q3 		– Sell
-1,412
Closed -$159K – 3911
2023
Q2 		$181K Sell
1,412
-104
-7% -$12.6K 0.03% 654
2023
Q1 		$176K Sell
1,516
-144
-9% -$16.1K 0.02% 745
2022
Q4 		$187K Sell
1,660
-2,665
-62% -$293K 0.02% 819
2022
Q3 		$348K Sell
4,325
-1,175
-21% -$99.5K 0.02% 699
2022
Q2 		$409K Buy
5,500
+5,100
+1,275% +$465K 0.03% 610
2022
Q1 		$51K Sell
400
-1,600
-80% -$175K ﹤0.01% 2227
2021
Q4 		$268K Sell
2,000
-8,400
-81% -$1.21M 0.01% 1107
2021
Q3 		$1.42M Buy
+10,400
New +$1.31M 0.06% 340
2018
Q4 		– Sell
-4,400
Closed -$157K – 4075
2018
Q3 		$157K Buy
+4,400
New +$136K 0.01% 955
2018
Q1 		– Sell
-13,368
Closed -$191K – 4617
2017
Q4 		$191K Buy
13,368
+8,956
+203% +$116K 0.01% 990
2017
Q3 		$53K Sell
4,412
-6,508
-60% -$115K ﹤0.01% 2184
2017
Q2 		$199K Sell
10,920
-46,180
-81% -$853K 0.01% 1284
2017
Q1 		$1.21M Sell
57,100
-21,732
-28% -$424K 0.05% 318
2016
Q4 		$1.18M Buy
78,832
+74,388
+1,674% +$1.32M 0.04% 353
2016
Q3 		$97K Sell
4,444
-43,292
-91% -$964K ﹤0.01% 1834
2016
Q2 		$946K Buy
47,736
+31,988
+203% +$545K 0.05% 305
2016
Q1 		$267K Buy
+15,748
New +$263K 0.02% 844

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Cutler Group's DXCM Position: Q1 2024 in Review

Cutler Group sold out of DexCom (DXCM) in Q1 2024, closing a stake of 455 shares — an estimated $57.2K sold.

Cutler Group first reported a position in DXCM in Q1 2016 and held it in 18 quarters. The position peaked at $1.42M in Q3 2021. 1,034 funds tracked by Wall St. Rank hold DXCM as of Q1 2024.

  • Cutler Group reported no remaining DexCom position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 455 DexCom shares in Q1 2024, an estimated $57.2K.
  • Cutler Group first reported a position in DexCom in Q1 2016 and held it in 18 quarters.
  • Cutler Group's DexCom position peaked at $1.42M in Q3 2021.
  • 1,034 funds tracked by Wall St. Rank held DexCom as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.